Biofrontera (BFRI) Return on Sales (2020 - 2025)

Biofrontera's Return on Sales history runs 6 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at Biofrontera, up from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2022 to a low of 0.04% in Q3 2021.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2021.
• The sharpest annual moves came in 2021 and 2022: Return on Sales fell 3 bps in 2021, then increased 3 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.02% in 2021, then soared by 83 bps to 0.0% in 2022, then jumped by 221 bps to 0.0% in 2023, then sank by 133 bps to 0.0% in 2024, then jumped by 397 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.